AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.590
-0.010 (-1.67%)
At close: Dec 27, 2024, 4:00 PM
0.600
+0.010 (1.69%)
After-hours: Dec 27, 2024, 7:50 PM EST
AEON Biopharma Market Cap
AEON Biopharma has a market cap or net worth of $23.58 million as of December 27, 2024. Its market cap has decreased by -89.73% in one year.
Market Cap
23.58M
Enterprise Value
39.55M
1-Year Change
-89.73%
Ranking
Category
Stock Price
$0.59
Market Cap Chart
Since April 12, 2021, AEON Biopharma's market cap has decreased from $63.66M to $23.58M, a decrease of -62.95%. That is a compound annual growth rate of -23.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2024 | 23.98M | -91.04% |
| Dec 29, 2023 | 267.55M | -80.82% |
| Dec 30, 2022 | 1.40B | 553.24% |
| Dec 30, 2021 | 213.58M | 235.51% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeuroSense Therapeutics | 25.16M |
| Cara Therapeutics | 24.68M |
| Akari Therapeutics, | 24.26M |
| Co-Diagnostics | 24.22M |
| DarioHealth | 23.64M |
| BriaCell Therapeutics | 23.35M |
| Gelteq | 23.22M |
| NextCure | 23.18M |